You can buy or sell Athersys and other stocks, options, ETFs, and crypto commission-free!
Athersys, Inc. engages in the discovery and development of therapies designed to extend and enhance to quality of human life. It offers MultiStem as its stem cell product which provides biological potency and therapeutic effects for distinct diseases and conditions in the cardiovascular, neurological, inflammatory, and immune disease areas. Read More The company was founded by John J. Harrington and Gil van Bokkelen on October 24, 1995 and is headquartered in Cleveland, OH. The listed name for ATHX is Athersys, Inc. Common Stock.
52 Week High
52 Week Low
— per share
Expected Nov 5, After Hours